Skip to main content
. 2020 Dec 17;156(2):61–64. doi: 10.1016/j.medcle.2020.08.004

Table 2.

Multivariate analysis of characteristics associated with loss of smell and taste in patients affected by COVID-19.

Variable OR 95% confidence interval p
Sex (female) 0.924 0.876 to 1.369 0.020
Age (> 60 years) 0.980 0.723 to 1.113 0.023
Comorbidities
 Diabetes mellitus 0.460 −2.308 to 0.756 0.321
 Arterial hypertension 0.626 −1.290 to 0.852 0.263
 WP or NP rhinosinusitis 0.692 −0.054 to 1.035 0.163
 Autoimmune disease (SLE, RA, etc.) 0.659 −1.571 to 0.737 0.479
 Hypothyroidism in treatment 0.525 −0.333 to 0.777 0.273
 Hypothyroidism without treatment 0.173 −0.460 to 0.449 0.268
 Allergic rhinitis 0.331 −0.199 to 0.455 0.790
 Renal failure 0.243 −0.188 to 0.356 0.281
 Liver failure 1.317 −0.070 to 1.468 0.064
 COPD 0.722 −0.236 to 0.932 0.394
 Asthma 1.200 −0.587 to 1.952 0.642
 Cardiac pathology 0.930 −0.522 to 1.837 0.275
 Neurodegenerative disease 0.144 −0.528 to 0.658 0.144
 Depression 0.611 −0.360 to 1.314 0.264
 Extrinsic allergies (pollen, grass, etc.) 0.532 −0.032 to 0.885 0.068
 Smoker 0.371 −0.674 to 0.615 0.929
Symptoms associated with COVID-19
 Fever > 38° 0.981 0.434 to 1.396 0.008
 Dry cough 1.202 −0.377 to 1.744 0.521
 Loss of appetite 0.482 −0.027 to 0.814 0.067
 Bronchial mucus-expectoration 0.978 −0.513 to 1.468 0.929
 Arthralgia 0.835 0.642 to 1.281 0.443
 Myalgia 1.038 0.449 to 1.524 0.123
 Diarrhoea 1.092 −0.321 to 1.497 0.673
 Abdominal pain 0.657 0.213 to 0.769 0.268
 Headache 1.160 0.917 to 1.313 0.021
ENT symptoms
 Nasal Congestion 0.997 0.145 to 1.139 0.967
 Rhinorrhoea 0.816 0.376 to -1.031 0.531
 Postnasal drip 1.019 0.425 to 1.163 0.799
 MF 1.007 0.546 to 0.160 0.931
 CF pain 1.240 0.376 to 1.354 0.102
 Earache 0.909 0.681 to 0.990 0.311
 Dysphagia 0.972 0.431 to 1.174 0.781
 Dyspnoea 0.951 0.605 to 1.104 0.521

RA: rheumatoid arthritis; WP : with polyps; COPD : chronic obstructive pulmonary disease; SLE : lupus erythematosus; OR : odds ratio; NP : without polyps.